Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Pneumonia96 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A00320 | 35138548 | Intern Emerg Med | NAFLD determined by Dallas Steatosis Index is associated with poor outcomes in COVID-19 pneumonia: a cohort study. | 2022 | Details |
| A02299 | 34431511 | Cochrane Database Syst Rev | Vitamin D supplementation for chronic liver diseases in adults. | 2021 | Details |
| A02820 | 34230921 | MedComm (2020) | Sex differences in clinical characteristics and risk factors for disease severity of hospitalized patients with COVID-19. | 2021 | Details |
| A02967 | 34181776 | Aliment Pharmacol Ther | Internal medicine hospitalisations and liver disease: a comparative disease burden analysis of a multicentre cohort. | 2021 | Details |
| A03059 | 34149320 | GastroHep | Liver injury, SARS-COV-2 infection and COVID-19: What physicians should really know? | 2021 | Details |
| A03256 | 34069176 | Life (Basel) | Kaempferol-3-O-Glucuronide Ameliorates Non-Alcoholic Steatohepatitis in High-Cholesterol-Diet-Induced Larval Zebrafish and HepG2 Cell Models via Regulating Oxidation Stress. | 2021 | Details |
| A03363 | 34027561 | Arch Toxicol | Infections at the nexus of metabolic-associated fatty liver disease. | 2021 | Details |
| A03446 | 33996143 | J Virus Erad | Prevention and control measures significantly curbed the SARS-CoV-2 and influenza epidemics in China. | 2021 | Details |
| A03509 | 33977096 | Can J Gastroenterol Hepatol | NAFLD and Infection, a Nuanced Relationship. | 2021 | Details |
| A03620 | 33928009 | Clin Nephrol Case Stud | Severe type-B lactic acidosis in a patient with bilateral renal Burkitt's lymphoma. | 2021 | Details |
| A03731 | 33887125 | United European Gastroenterol J | Gut fermentation syndrome: A systematic review of case reports. | 2021 | Details |
| A04596 | 33569476 | Ann Transl Med | A narrative review of the roles of indoleamine 2,3-dioxygenase and tryptophan-2,3-dioxygenase in liver diseases. | 2021 | Details |
| A05026 | 33406286 | Int J Clin Pract | Small intestinal bacterial overgrowth and non-alcoholic fatty liver disease diagnosed by transient elastography and liver biopsy. | 2021 | Details |
| A05533 | 33216772 | PLoS One | Performance of serum apolipoprotein-A1 as a sentinel of Covid-19. | 2020 | Details |
| A06043 | 33031439 | PLoS One | In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19. | 2020 | Details |
| A06471 | 32867260 | Medicina (Kaunas) | Probiotics: Versatile Bioactive Components in Promoting Human Health. | 2020 | Details |
| A06531 | 32838396 | MedComm (2020) | Radiomics-based model for accurately distinguishing between severe acute respiratory syndrome associated coronavirus 2 (SARS-CoV-2) and influenza A infected pneumonia. | 2020 | Details |
| A06623 | 32803716 | Indian J Gastroenterol | Poor outcomes in patients with cirrhosis and Corona Virus Disease-19. | 2020 | Details |
| A06821 | 32734407 | Hepatol Int | Effect of COVID-19 on patients with compensated chronic liver diseases. | 2020 | Details |
| A06841 | 32727662 | Gastroenterol Hepatol | COVID-19 and liver disease: An update. | 2020 | Details |
| A07096 | 32623632 | Hepatol Int | Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study). | 2020 | Details |
| A07175 | 32592657 | Cell Metab | In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19. | 2020 | Details |
| A07188 | 32589264 | Eur J Clin Invest | COVID-19 and non-alcoholic fatty liver disease: Two intersecting pandemics. | 2020 | Details |
| A07200 | 32585136 | Lancet Gastroenterol Hepatol | Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement. | 2020 | Details |
| A07238 | 32571616 | Nutr Metab Cardiovasc Dis | Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies. | 2020 | Details |
| A07257 | 32564624 | Ann Saudi Med | Principles of Care for Patients with Liver Disease During the Coronavirus Disease 2019 (COVID-19) Pandemic: Position Statement of the Saudi Association for the Study of Liver Disease and Transplantation. | 2020 | Details |
| A07319 | 32540736 | Diabetes Metab Syndr | Metabolic dysfunction associated fatty liver disease increases risk of severe Covid-19. | 2020 | Details |
| A07478 | 32479709 | Transpl Infect Dis | Isolated pulmonary fusariosis caused by Neocosmospora pseudensiformis in a liver transplant recipient: A case report and review of the literature. | 2020 | Details |
| A07632 | 32414383 | Ann Clin Microbiol Antimicrob | Plasma CRP level is positively associated with the severity of COVID-19. | 2020 | Details |
| A07668 | 32402090 | Aliment Pharmacol Ther | Review article: COVID-19 and liver disease-what we know on 1st May 2020. | 2020 | Details |
| A07949 | 32302265 | Circ Res | Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19. | 2020 | Details |
| A08028 | 32277591 | Am J Transplant | Fatal outcome in a liver transplant recipient with COVID-19. | 2020 | Details |
| A08331 | 32150306 | J Gastroenterol Hepatol | Endogenous ethanol produced by intestinal bacteria induces mitochondrial dysfunction in non-alcoholic fatty liver disease. | 2020 | Details |
| A08696 | 32019793 | mBio | Endotoxin Producers Overgrowing in Human Gut Microbiota as the Causative Agents for Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A09263 | 31813265 | Antioxid Redox Signal | Redox Regulation via Glutaredoxin-1 and Protein S-Glutathionylation. | 2020 | Details |
| A09960 | 31543403 | Cell Metab | Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae. | 2019 | Details |
| A12691 | 30325458 | QJM | Non-alcoholic fatty liver disease and 30-day all-cause mortality in adult patients with community-acquired pneumonia. | 2019 | Details |
| A15947 | 28640662 | Gut Microbes | Using probiotics in clinical practice: Where are we now? A review of existing meta-analyses. | 2017 | Details |
| A24940 | 22334337 | Hepatology | Specific immunization strategies against oxidized low-density lipoprotein: a novel way to reduce nonalcoholic steatohepatitis in mice. | 2012 | Details |
| A28204 | 16149155 | World J Gastroenterol | Liver cirrhosis induced by long-term administration of a daily low dose of amiodarone: a case report. | 2005 | Details |
| A29173 | 34473374 | FASEB J | Novel approaches to intervene gut microbiota in the treatment of chronic liver diseases. | 2021 | Details |
| A29603 | 33811104 | J Immunol | Glycolipid-Containing Nanoparticle Vaccine Engages Invariant NKT Cells to Enhance Humoral Protection against Systemic Bacterial Infection but Abrogates T-Independent Vaccine Responses. | 2021 | Details |
| A30205 | 32810418 | Popul Health Manag | We Know Health Is Not Elective: Impacts of COVID-19. | 2020 | Details |
| A30228 | 32785416 | Rev Saude Publica | Choosing a hospital assistance ship to fight the covid-19 pandemic. | 2020 | Details |
| A30271 | 32717195 | J Theor Biol | Optimal strategies for vaccination and social distancing in a game-theoretic epidemiologic model. | 2020 | Details |
| A30362 | 32565199 | Clin Res Hepatol Gastroenterol | Clinical characteristics and management of a liver transplanted patient admitted with SARS-CoV-2 infection. | 2020 | Details |
| A31212 | 31024197 | J Clin Exp Hepatol | A/H1N1/09 Influenza is Associated With High Mortality in Liver Cirrhosis. | 2018 | Details |
| A33159 | 26579446 | Acta Pharm Sin B | Kallistatin, a new and reliable biomarker for the diagnosis of liver cirrhosis. | 2015 | Details |
| A34789 | 22592920 | Am J Respir Cell Mol Biol | Hydrogen sulfide attenuates particulate matter-induced human lung endothelial barrier disruption via combined reactive oxygen species scavenging and Akt activation. | 2012 | Details |
| A35582 | 20238251 | Dig Dis Sci | Anti-thymocyte globulin for the treatment of acute cellular rejection following liver transplantation. | 2010 | Details |
| A35636 | 22798443 | BMJ Case Rep | A hot, swollen joint in a cirrhotic patient. | 2010 | Details |
| A37260 | 16133366 | Virchows Arch | Hepatocellular carcinoma and nonalcoholic steatohepatitis developing during long-term administration of valproic acid. | 2005 | Details |
| A43022 | 32794597 | Hepatology | Maintaining Patient Safety and Data Integrity of Nonalcoholic Steatohepatitis Clinical Trials During the Severe Acute Respiratory Syndrome-Coronavirus 2 Pandemic. | 2020 | Details |
| A43123 | 32507608 | Eur J Intern Med | Hepatic consequences of COVID-19 infection. Lapping or biting? | 2020 | Details |
| A43138 | 32445883 | J Hepatol | Lack of genetic evidence that fatty liver disease predisposes to COVID-19. | 2020 | Details |
| A43155 | 32414813 | Gut | Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores. | 2020 | Details |
| A43178 | 32360995 | J Hepatol | No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease. | 2020 | Details |
| A43179 | 32360211 | Metabolism | Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease. | 2020 | Details |
| A43181 | 32356701 | Med Sci (Paris) | [Intestinal bacteria involved in nutritional liver disease killed by phagotherapy: a new therapeutic target]. | 2020 | Details |
| A43185 | 32353356 | Metabolism | Commentary: Obesity: The "Achilles heel" for COVID-19? | 2020 | Details |
| A43199 | 32320741 | Metabolism | Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease. | 2020 | Details |
| A43210 | 32278005 | J Hepatol | Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study. | 2020 | Details |
| A43219 | 32266419 | Arch Toxicol | COVID-19 and drug-induced liver injury: a problem of plenty or a petty point? | 2020 | Details |
| A43611 | 31294797 | J Burn Care Res | The Influence of Obesity on Treatment and Outcome of Severely Burned Patients. | 2019 | Details |
| A44502 | 28457103 | Isr Med Assoc J | Association between non-alcoholic fatty liver disease and hospitalized patients with community-acquired pneumonia. | 2017 | Details |
| A45382 | 24895841 | Scand J Gastroenterol | National trends and inpatient outcomes of inflammatory bowel disease patients with concomitant chronic liver disease. | 2014 | Details |
| A45784 | 22763792 | Curr Gastroenterol Rep | Fighting fire with fire: is it time to use probiotics to manage pathogenic bacterial diseases? | 2012 | Details |
| A47142 | 25104501 | Am J Physiol Gastrointest Liver Physiol | An alteration of the gut-liver axis drives pulmonary inflammation after intoxication and burn injury in mice. | 2014 | Details |
| A47660 | 34101656 | JBJS Case Connect | Early Postoperative Pneumonia After Elective Primary Total Hip Arthroplasty in "COVID-19 Survivor": A Case Report. | 2021 | Details |
| A47725 | 32908723 | Case Rep Endocrinol | Development of Fulminant Type 1 Diabetes Mellitus in a Patient with DRESS Syndrome. | 2020 | Details |
| A47734 | 32739404 | Antiviral Res | The chemokine receptor antagonist cenicriviroc inhibits the replication of SARS-CoV-2 in vitro. | 2020 | Details |
| A48109 | 23226929 | Mediators Inflamm | Simulating sleep apnea by exposure to intermittent hypoxia induces inflammation in the lung and liver. | 2012 | Details |
| A48343 | 15986871 | Dig Dis Sci | High rate of seropositivity of Chlamydia pneumoniae IgA in male patients with nonalcoholic steatohepatitis. | 2005 | Details |
| A49318 | 35790018 | Hepatology | Age and the relative importance of liver-related deaths in nonalcoholic fatty liver disease. | 2022 | Details |
| A49700 | 35665122 | World J Clin Cases | COVID-19 and liver diseases, what we know so far. | 2022 | Details |
| A49918 | 35596929 | Hepatology | Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease. | 2022 | Details |
| A49981 | 35573976 | Respir Med Case Rep | Pneumocystis pneumonia in an immunocompetent patient developing a subacute disease course with central consolidation. | 2022 | Details |
| A50034 | 35555962 | Intern Med J | The short-term outcomes of patients with chronic liver disease hospitalized with COVID-19. | 2022 | Details |
| A50218 | 35469129 | J Clin Exp Hepatol | Is Fatty Liver associated with increased mortality and morbidity in patients with COVID-19 pneumonia? | 2022 | Details |
| A50930 | 32694292 | Am J Gastroenterol | ACE2: A Linkage for the Interplay Between COVID-19 and Decompensated Cirrhosis. | 2020 | Details |
| A50933 | 32496914 | Circ Res | Response by Zhang et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19". | 2020 | Details |
| A50935 | 32454505 | Nephron | Subclinical Acute Kidney Injury in COVID-19 Patients: A Retrospective Cohort Study. | 2020 | Details |
| A50937 | 32333938 | Metabolism | Letter to the Editor: Obesity hypoventilation syndrome and severe COVID-19. | 2020 | Details |
| A50938 | 32314129 | J Gen Intern Med | A Case Series of Recurrent Viral RNA Positivity in Recovered COVID-19 Chinese Patients. | 2020 | Details |
| A51311 | 35702843 | J Assoc Physicians India | Spontaneous Ascitic Fluid Infection: Are we Experiencing an Epidemiological shift in Causative Organisms? | 2022 | Details |
| A51526 | 35592303 | Can J Infect Dis Med Microbiol | A Novel Predictive Model in Recognizing Severe COVID-19 and Multiorgan Injuries: Platelet-to-CRP Ratio. | 2022 | Details |
| A51558 | 35145555 | Drugs Context | Dabigatran in patients with atrial fibrillation after COVID-19 hospitalization: an update of the ANIBAL protocol. | 2022 | Details |
| A51613 | 35660447 | Sci Total Environ | Metabolomics-based safety evaluation of acute exposure to electronic cigarettes in mice. | 2022 | Details |
| A51709 | 34722191 | J Clin Transl Hepatol | COVID-19 and Indirect Liver Injury: A Narrative Synthesis of the Evidence. | 2021 | Details |
| A51816 | 33942721 | Elife | Metabolic biomarker profiling for identification of susceptibility to severe pneumonia and COVID-19 in the general population. | 2021 | Details |
| A51963 | 32842793 | Expert Rev Gastroenterol Hepatol | Data sharing during COVID-19 pandemic: what to take away. | 2020 | Details |
| A51974 | 32705906 | Expert Rev Gastroenterol Hepatol | MAFLD in COVID-19 patients: an insidious enemy. | 2020 | Details |
| A51977 | 32683613 | Abdom Radiol (NY) | Higher frequency of hepatic steatosis at CT among COVID-19-positive patients. | 2020 | Details |
| A51981 | 32633236 | J Physiol Pharmacol | COVID-19 - more than respiratory disease: a gastroenterologist's perspective. | 2020 | Details |
| A51990 | 32573883 | Liver Int | Metabolic-associated fatty liver disease is associated with severity of COVID-19. | 2020 | Details |
| A52008 | 32387073 | J Hepatol | Reply to: 'No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease'. | 2020 | Details |